Standardized protocol profiles protein corona on nanoparticles, achieving 90% classification accuracy for early cancer detection.
The formation of a personalized protein corona (PC) on nanoparticles (NPs) upon exposure to biological fluids has emerged as a promising, minimally invasive strategy for early cancer detection. This study introduces a standardized protocol for profiling the protein corona using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), optimized to ensure robustness, reproducibility, and automation. The method was rigorously validated across a variety of nanoparticle (NP) platforms, plasma sources, and experimental conditions, demonstrating consistently reproducible profiles with minimal operator-dependent variability. In comparison to conventional proteomics techniques, this approach offers a faster, more cost-effective solution that meets the World Health Organization's REASSURED criteria for diagnostics. When applied to pancreatic ductal adenocarcinoma (PDAC), a highly aggressive malignancy with limited early biomarkers, this workflow achieved classification accuracies of up to 90%, even in early-stage patients. This standardized platform marks a significant advancement towards scalable, clinically translatable, and affordable diagnostic tools for cancer screening.
No takes yet. Share an insight, caveat, or question.
Quagliarini et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: